
{"id":117682,"date":"2024-05-15T11:00:00","date_gmt":"2024-05-15T09:00:00","guid":{"rendered":"https:\/\/ibecbarcelona.eu\/?p=117682"},"modified":"2024-05-14T13:28:58","modified_gmt":"2024-05-14T11:28:58","slug":"new-biomarker-to-diagnose-alzheimers-in-asymptomatic-stages","status":"publish","type":"post","link":"https:\/\/ibecbarcelona.eu\/ca\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques","title":{"rendered":"Nou biomarcador per diagnosticar l&#8217;alzheimer en etapes asimptom\u00e0tiques"},"content":{"rendered":"\n<p><strong>Es tracta d&#8217;una mol\u00e8cula que est\u00e0 directament relacionada amb l&#8217;expressi\u00f3 de la prote\u00efna pri\u00f2nica cel\u00b7lular, present a la superf\u00edcie de les c\u00e8l\u00b7lules neurals.<\/strong> <strong>L&#8217;estudi, liderat per l&#8217;IBEC, obre la porta a la detecci\u00f3 primerenca de la malaltia d&#8217;Alzheimer en etapes asimptom\u00e0tiques en mostres de sang, afavorint el seu diagn\u00f2stic i tractament.<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"683\" data-src=\"https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2024\/05\/DelRio-RGavin-DJacome_3-recorte_low-1024x683.png\" alt=\"\" class=\"wp-image-117663 lazyload\" data-srcset=\"https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2024\/05\/DelRio-RGavin-DJacome_3-recorte_low-1024x683.png 1024w, https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2024\/05\/DelRio-RGavin-DJacome_3-recorte_low-300x200.png 300w, https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2024\/05\/DelRio-RGavin-DJacome_3-recorte_low-768x512.png 768w, https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2024\/05\/DelRio-RGavin-DJacome_3-recorte_low-600x400.png 600w, https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2024\/05\/DelRio-RGavin-DJacome_3-recorte_low.png 1200w\" data-sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" style=\"--smush-placeholder-width: 1024px; --smush-placeholder-aspect-ratio: 1024\/683;\" \/><figcaption class=\"wp-element-caption\">D&#8217;esquerra a dreta: Rosalina Gav\u00edn, Jos\u00e9 Antonio del R\u00edo i Dayaneth J\u00e1come.<\/figcaption><\/figure>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>Un estudi recent, liderat pel <a href=\"https:\/\/ibecbarcelona.eu\/es\/neurobiotechnology\">grup de Neurobiotecnologia Molecular i Cel\u00b7lular<\/a> de l&#8217;IBEC i de la Universitat de Barcelona, ha identificat un nou biomarcador d&#8217;alzheimer en estadis asimptom\u00e0tics de la malaltia. Es tracta de la mol\u00e8cula miR-519a-3p, un microARN que est\u00e0 directament relacionat amb l&#8217;expressi\u00f3 de la prote\u00efna pri\u00f2nica cel\u00b7lular (PrP<sup>C<\/sup>), la qual es troba desregulada en persones que pateixen algunes malalties neurodegeneratives com l&#8217;alzheimer.<\/p>\n\n\n\n<p>La recerca de biomarcadors que siguin estables i f\u00e0cilment detectables en biofluids, com els microARN, brinda esperances per a la detecci\u00f3 primerenca de l&#8217;alzheimer en les seves etapes asimptom\u00e0tiques inicials, cosa que podria ajudar en el diagn\u00f2stic i tractament primerenc d&#8217;aquesta malaltia que afecta m\u00e9s de 35 milions de persones a tot el m\u00f3n.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong><strong>Primera vegada que es relacionen miR-519a-3p i PrP<sup>C<\/sup> en alzheimer<\/strong><\/strong><\/h4>\n\n\n\n<p>Se sap que l&#8217;expressi\u00f3 d&#8217;alguns microARN est\u00e0 desregulada en pacients amb alzheimer. No obstant aix\u00f2, \u00e9s la primera vegada que aquest microARN s&#8217;ha relacionat espec\u00edficament amb la disminuci\u00f3 en la producci\u00f3 de la prote\u00efna pri\u00f2nica cel\u00b7lular durant la progressi\u00f3 de la malaltia.<\/p>\n\n\n\n<p>&#8220;Actualment, les proves per diagnosticar la malaltia d&#8217;Alzheimer solen dur-se a terme despr\u00e9s de l&#8217;aparici\u00f3 dels primers s\u00edmptomes, quan ja hi ha un deteriorament cognitiu subjacent. Creiem que la detecci\u00f3 d&#8217;aquest microARN pot ajudar a establir criteris addicionals per a un diagn\u00f2stic m\u00e9s prec\u00eds en les fases inicials de la malaltia.&#8221;,\u00a0explica Jos\u00e9 Antonio del R\u00edo, investigador principal de l&#8217;IBEC, catedr\u00e0tic de la Facultat de Biologia y de l\u2019Institut de Neuroci\u00e8ncies (UBneuro) de la Universitat de Barcelona (UB) i col\u00edder de l&#8217;estudi.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>Creiem que la detecci\u00f3 d&#8217;aquest microARN pot ajudar a establir criteris addicionals per a un diagn\u00f2stic m\u00e9s prec\u00eds en les fases inicials de la malaltia.<\/p>\n<cite>Jos\u00e9 Antonio del R\u00edo<\/cite><\/blockquote>\n\n\n\n<p>A m\u00e9s, el treball analitza de forma comparativa la pres\u00e8ncia del biomarcador en mostres d&#8217;altres malalties neurodegeneratives:<\/p>\n\n\n\n<p>&#8220;Si el nostre objectiu \u00e9s utilitzar miR-519a-3p com a biomarcador per detectar dem\u00e8ncia de tipus alzheimer en persones hipot\u00e8ticament sanes, \u00e9s clau assegurar-se que els seus nivells no estiguin alterats en altres malalties neurodegeneratives. En el nostre estudi, comparem els nivells d&#8217;aquest biomarcador en mostres d&#8217;altres taupaties i Parkinson, confirmant que els canvis del miR-519a-3p s\u00f3n espec\u00edfics de la malaltia d&#8217;Alzheimer&#8221;, detalla Rosalina Gav\u00edn, investigadora s\u00e8nior de l&#8217;IBEC, professora agregada de la UB i l\u2019UBneuro i col\u00edder de l&#8217;estudi.<\/p>\n\n\n\n<p>L&#8217;equip avan\u00e7a en la seva investigaci\u00f3, com indica Dayaneth J\u00e1come, investigadora en el grup de del R\u00edo i primera autora de l&#8217;estudi &#8220;el seg\u00fcent pas \u00e9s la validaci\u00f3 del miR-519a-3p com a biomarcador en mostres de sang de diferents cohorts de pacients, per comen\u00e7ar a emprar-lo en el diagn\u00f2stic cl\u00ednic d&#8217;alzheimer en mostres perif\u00e8riques&#8221;.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>El seg\u00fcent pas \u00e9s la validaci\u00f3 del miR-519a-3p com a biomarcador en mostres de sang de diferents cohorts de pacients.<\/p>\n<cite>Dayaneth J\u00e1come<\/cite><\/blockquote>\n\n\n\n<p>Els investigadors s\u00f3n membres del Centre de recerca en Xarxa de Malalties Neurodegeneratives, CIBERNED.<\/p>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h4 class=\"wp-block-heading\"><strong><strong>Els microARNs: silenciadors de gens<\/strong><\/strong><\/h4>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"771\" data-src=\"https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2024\/05\/Tv5-1-1024x771.jpg\" alt=\"\" class=\"wp-image-117677 lazyload\" style=\"--smush-placeholder-width: 1024px; --smush-placeholder-aspect-ratio: 1024\/771;object-fit:cover\" data-srcset=\"https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2024\/05\/Tv5-1-1024x771.jpg 1024w, https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2024\/05\/Tv5-1-300x226.jpg 300w, https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2024\/05\/Tv5-1-768x578.jpg 768w\" data-sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" \/><figcaption class=\"wp-element-caption\">Fotografia al microscopi \u00f2ptic d&#8217;una secci\u00f3 d&#8217;escor\u00e7a frontal humana post mortem d&#8217;un pacient amb malaltia d&#8217;Alzheimer escala o grau VI de Braak (el m\u00e9s avan\u00e7at). S&#8217;aprecien neurones amb elevat contingut de prote\u00efna tau.<\/figcaption><\/figure>\n\n\n\n<p>La quantitat de prote\u00efna pri\u00f2nica cel\u00b7lular canvia durant la progressi\u00f3 de l&#8217;alzheimer, mostrant nivells m\u00e9s alts en les primeres etapes de la malaltia i disminuint a mesura que avan\u00e7a la mateixa. Tot i que no es coneix en detall el mecanisme responsable d&#8217;aquests canvis, s&#8217;ha observat que certs microARN s&#8217;uneixen a una regi\u00f3 espec\u00edfica del gen <em>PRNP<\/em>, que controla l&#8217;expressi\u00f3 de PrP<sup>C<\/sup>, disminuint-la. Per aix\u00f2, i basant-se en comparacions d&#8217;estudis previs i an\u00e0lisi computacional en diverses bases de dades gen\u00f2miques, els investigadors van seleccionar el microARN miR-519a-3p per al seu estudi.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p><strong>Article referenciat:<\/strong><\/p>\n\n\n\n<p>Dayaneth J\u00e1come, Tiziana Cotrufo, Pol Andr\u00e9s-Benito, Laia Lid\u00f3n, Eul\u00e0lia Mart\u00ed, Isidre Ferrer, Jos\u00e9 Antonio del R\u00edo, Rosalina Gav\u00edn. <strong>miR-519a-3p, found to regulate cellular prion protein during Alzheimer\u2019s disease pathogenesis, as a biomarker of asymptomatic stages<\/strong>. <em>BBA &#8211; Molecular Basis of Disease<\/em> (2024). DOI: <a href=\"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167187\">https:\/\/doi.org\/10.1016\/j.bbadis.2024.167187<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Es tracta d&#8217;una mol\u00e8cula que est\u00e0 directament relacionada amb l&#8217;expressi\u00f3 de la prote\u00efna pri\u00f2nica cel\u00b7lular, present a la superf\u00edcie de les c\u00e8l\u00b7lules neurals. L&#8217;estudi, liderat per l&#8217;IBEC, obre la porta a la detecci\u00f3 primerenca de la malaltia d&#8217;Alzheimer en etapes asimptom\u00e0tiques en mostres de sang, afavorint el seu diagn\u00f2stic i tractament.<\/p>\n","protected":false},"author":37,"featured_media":117664,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[96],"tags":[1627,2119,1132,1581],"post_formats":[],"class_list":["post-117682","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticies-de-recerca","tag-alzheimer-ca-2","tag-dementia-ca","tag-jose-antonio-del-rio-ca","tag-molecular-and-cellular-neurobiotechnology-group-ca"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nou biomarcador per diagnosticar l&#039;alzheimer en etapes asimptom\u00e0tiques - Institute for Bioengineering of Catalonia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibecbarcelona.eu\/ca\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nou biomarcador per diagnosticar l&#039;alzheimer en etapes asimptom\u00e0tiques - Institute for Bioengineering of Catalonia\" \/>\n<meta property=\"og:description\" content=\"Es tracta d&#039;una mol\u00e8cula que est\u00e0 directament relacionada amb l&#039;expressi\u00f3 de la prote\u00efna pri\u00f2nica cel\u00b7lular, present a la superf\u00edcie de les c\u00e8l\u00b7lules neurals. L&#039;estudi, liderat per l&#039;IBEC, obre la porta a la detecci\u00f3 primerenca de la malaltia d&#039;Alzheimer en etapes asimptom\u00e0tiques en mostres de sang, afavorint el seu diagn\u00f2stic i tractament.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibecbarcelona.eu\/ca\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\/\" \/>\n<meta property=\"og:site_name\" content=\"Institute for Bioengineering of Catalonia\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-15T09:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2024\/05\/DelRio-RGavin-DJacome_3-recorte_low.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Sarah Moreira\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sarah Moreira\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\\\/\"},\"author\":{\"name\":\"Sarah Moreira\",\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/#\\\/schema\\\/person\\\/d3a158b8d448000777023ca1e3d71d34\"},\"headline\":\"Nou biomarcador per diagnosticar l&#8217;alzheimer en etapes asimptom\u00e0tiques\",\"datePublished\":\"2024-05-15T09:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\\\/\"},\"wordCount\":814,\"publisher\":{\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ibecbarcelona.eu\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/DelRio-RGavin-DJacome_3-recorte_low.png\",\"keywords\":[\"Alzheimer\",\"dementia\",\"Jos\u00e9 Antonio del R\u00edo\",\"Molecular and cellular neurobiotechnology group\"],\"articleSection\":[\"Not\u00edcies de recerca\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\\\/\",\"url\":\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\\\/\",\"name\":\"Nou biomarcador per diagnosticar l'alzheimer en etapes asimptom\u00e0tiques - Institute for Bioengineering of Catalonia\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ibecbarcelona.eu\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/DelRio-RGavin-DJacome_3-recorte_low.png\",\"datePublished\":\"2024-05-15T09:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\\\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ibecbarcelona.eu\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/DelRio-RGavin-DJacome_3-recorte_low.png\",\"contentUrl\":\"https:\\\/\\\/ibecbarcelona.eu\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/DelRio-RGavin-DJacome_3-recorte_low.png\",\"width\":1200,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nou biomarcador per diagnosticar l&#8217;alzheimer en etapes asimptom\u00e0tiques\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/#website\",\"url\":\"https:\\\/\\\/ibecbarcelona.eu\\\/\",\"name\":\"Institute for Bioengineering of Catalonia\",\"description\":\"Bioengineering Solutions for Health\",\"publisher\":{\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibecbarcelona.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/#organization\",\"name\":\"Institute for Bioengineering of Catalonia\",\"url\":\"https:\\\/\\\/ibecbarcelona.eu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ibecbarcelona.eu\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/cropped-IBEC_20ANYS_GRIS.png\",\"contentUrl\":\"https:\\\/\\\/ibecbarcelona.eu\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/cropped-IBEC_20ANYS_GRIS.png\",\"width\":696,\"height\":257,\"caption\":\"Institute for Bioengineering of Catalonia\"},\"image\":{\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/#\\\/schema\\\/person\\\/d3a158b8d448000777023ca1e3d71d34\",\"name\":\"Sarah Moreira\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/37385a1f83bdef106d1b89522da4c620ee48ba2eb0662dbc73ba05b7f3fbdf89?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/37385a1f83bdef106d1b89522da4c620ee48ba2eb0662dbc73ba05b7f3fbdf89?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/37385a1f83bdef106d1b89522da4c620ee48ba2eb0662dbc73ba05b7f3fbdf89?s=96&d=mm&r=g\",\"caption\":\"Sarah Moreira\"},\"url\":\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/author\\\/smoreira\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nou biomarcador per diagnosticar l'alzheimer en etapes asimptom\u00e0tiques - Institute for Bioengineering of Catalonia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibecbarcelona.eu\/ca\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\/","og_locale":"ca_ES","og_type":"article","og_title":"Nou biomarcador per diagnosticar l'alzheimer en etapes asimptom\u00e0tiques - Institute for Bioengineering of Catalonia","og_description":"Es tracta d'una mol\u00e8cula que est\u00e0 directament relacionada amb l'expressi\u00f3 de la prote\u00efna pri\u00f2nica cel\u00b7lular, present a la superf\u00edcie de les c\u00e8l\u00b7lules neurals. L'estudi, liderat per l'IBEC, obre la porta a la detecci\u00f3 primerenca de la malaltia d'Alzheimer en etapes asimptom\u00e0tiques en mostres de sang, afavorint el seu diagn\u00f2stic i tractament.","og_url":"https:\/\/ibecbarcelona.eu\/ca\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\/","og_site_name":"Institute for Bioengineering of Catalonia","article_published_time":"2024-05-15T09:00:00+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2024\/05\/DelRio-RGavin-DJacome_3-recorte_low.png","type":"image\/png"}],"author":"Sarah Moreira","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"Sarah Moreira","Temps estimat de lectura":"4 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ibecbarcelona.eu\/ca\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\/#article","isPartOf":{"@id":"https:\/\/ibecbarcelona.eu\/ca\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\/"},"author":{"name":"Sarah Moreira","@id":"https:\/\/ibecbarcelona.eu\/#\/schema\/person\/d3a158b8d448000777023ca1e3d71d34"},"headline":"Nou biomarcador per diagnosticar l&#8217;alzheimer en etapes asimptom\u00e0tiques","datePublished":"2024-05-15T09:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/ibecbarcelona.eu\/ca\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\/"},"wordCount":814,"publisher":{"@id":"https:\/\/ibecbarcelona.eu\/#organization"},"image":{"@id":"https:\/\/ibecbarcelona.eu\/ca\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\/#primaryimage"},"thumbnailUrl":"https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2024\/05\/DelRio-RGavin-DJacome_3-recorte_low.png","keywords":["Alzheimer","dementia","Jos\u00e9 Antonio del R\u00edo","Molecular and cellular neurobiotechnology group"],"articleSection":["Not\u00edcies de recerca"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/ibecbarcelona.eu\/ca\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\/","url":"https:\/\/ibecbarcelona.eu\/ca\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\/","name":"Nou biomarcador per diagnosticar l'alzheimer en etapes asimptom\u00e0tiques - Institute for Bioengineering of Catalonia","isPartOf":{"@id":"https:\/\/ibecbarcelona.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ibecbarcelona.eu\/ca\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\/#primaryimage"},"image":{"@id":"https:\/\/ibecbarcelona.eu\/ca\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\/#primaryimage"},"thumbnailUrl":"https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2024\/05\/DelRio-RGavin-DJacome_3-recorte_low.png","datePublished":"2024-05-15T09:00:00+00:00","breadcrumb":{"@id":"https:\/\/ibecbarcelona.eu\/ca\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibecbarcelona.eu\/ca\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/ibecbarcelona.eu\/ca\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\/#primaryimage","url":"https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2024\/05\/DelRio-RGavin-DJacome_3-recorte_low.png","contentUrl":"https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2024\/05\/DelRio-RGavin-DJacome_3-recorte_low.png","width":1200,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/ibecbarcelona.eu\/ca\/nou-biomarcador-per-diagnosticar-alzheimer-en-etapes-asimptomatiques\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ibecbarcelona.eu\/ca\/"},{"@type":"ListItem","position":2,"name":"Nou biomarcador per diagnosticar l&#8217;alzheimer en etapes asimptom\u00e0tiques"}]},{"@type":"WebSite","@id":"https:\/\/ibecbarcelona.eu\/#website","url":"https:\/\/ibecbarcelona.eu\/","name":"Institute for Bioengineering of Catalonia","description":"Bioengineering Solutions for Health","publisher":{"@id":"https:\/\/ibecbarcelona.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibecbarcelona.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/ibecbarcelona.eu\/#organization","name":"Institute for Bioengineering of Catalonia","url":"https:\/\/ibecbarcelona.eu\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/ibecbarcelona.eu\/#\/schema\/logo\/image\/","url":"https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2026\/01\/cropped-IBEC_20ANYS_GRIS.png","contentUrl":"https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2026\/01\/cropped-IBEC_20ANYS_GRIS.png","width":696,"height":257,"caption":"Institute for Bioengineering of Catalonia"},"image":{"@id":"https:\/\/ibecbarcelona.eu\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ibecbarcelona.eu\/#\/schema\/person\/d3a158b8d448000777023ca1e3d71d34","name":"Sarah Moreira","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/secure.gravatar.com\/avatar\/37385a1f83bdef106d1b89522da4c620ee48ba2eb0662dbc73ba05b7f3fbdf89?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/37385a1f83bdef106d1b89522da4c620ee48ba2eb0662dbc73ba05b7f3fbdf89?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/37385a1f83bdef106d1b89522da4c620ee48ba2eb0662dbc73ba05b7f3fbdf89?s=96&d=mm&r=g","caption":"Sarah Moreira"},"url":"https:\/\/ibecbarcelona.eu\/ca\/author\/smoreira\/"}]}},"AFP_featured_media_urls":{"full":["https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2024\/05\/DelRio-RGavin-DJacome_3-recorte_low.png",1200,800,false],"thumbnail":["https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2024\/05\/DelRio-RGavin-DJacome_3-recorte_low-150x150.png",150,150,true],"medium":["https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2024\/05\/DelRio-RGavin-DJacome_3-recorte_low-300x200.png",300,200,true],"medium_large":["https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2024\/05\/DelRio-RGavin-DJacome_3-recorte_low-768x512.png",768,512,true],"large":["https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2024\/05\/DelRio-RGavin-DJacome_3-recorte_low-1024x683.png",1024,683,true]},"AFP_attachments":{"full":["https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2024\/05\/DelRio-RGavin-DJacome_3-recorte_low.png",1200,800,false],"thumbnail":["https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2024\/05\/DelRio-RGavin-DJacome_3-recorte_low-150x150.png",150,150,true],"medium":["https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2024\/05\/DelRio-RGavin-DJacome_3-recorte_low-300x200.png",300,200,true],"medium_large":["https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2024\/05\/DelRio-RGavin-DJacome_3-recorte_low-768x512.png",768,512,true],"large":["https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2024\/05\/DelRio-RGavin-DJacome_3-recorte_low-1024x683.png",1024,683,true]},"AFP_videos":[],"AFP_video_blocks":"","AFP_category_names":["Not\u00edcies de recerca"],"_links":{"self":[{"href":"https:\/\/ibecbarcelona.eu\/ca\/wp-json\/wp\/v2\/posts\/117682","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibecbarcelona.eu\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibecbarcelona.eu\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibecbarcelona.eu\/ca\/wp-json\/wp\/v2\/users\/37"}],"replies":[{"embeddable":true,"href":"https:\/\/ibecbarcelona.eu\/ca\/wp-json\/wp\/v2\/comments?post=117682"}],"version-history":[{"count":1,"href":"https:\/\/ibecbarcelona.eu\/ca\/wp-json\/wp\/v2\/posts\/117682\/revisions"}],"predecessor-version":[{"id":117685,"href":"https:\/\/ibecbarcelona.eu\/ca\/wp-json\/wp\/v2\/posts\/117682\/revisions\/117685"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ibecbarcelona.eu\/ca\/wp-json\/wp\/v2\/media\/117664"}],"wp:attachment":[{"href":"https:\/\/ibecbarcelona.eu\/ca\/wp-json\/wp\/v2\/media?parent=117682"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibecbarcelona.eu\/ca\/wp-json\/wp\/v2\/categories?post=117682"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibecbarcelona.eu\/ca\/wp-json\/wp\/v2\/tags?post=117682"},{"taxonomy":"post_format","embeddable":true,"href":"https:\/\/ibecbarcelona.eu\/ca\/wp-json\/wp\/v2\/post_formats?post=117682"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}